期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Imipramine protects retinal ganglion cells from oxidative stress through the tyrosine kinase receptor B signaling pathway 被引量:5
1
作者 Ming-lei Han Guo-hua Liu +2 位作者 Jin Guo Shu-juan Yu Jing Huang 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第3期476-479,共4页
Retinal ganglion cell(RGC) degeneration is irreversible in glaucoma and tyrosine kinase receptor B(Trk B)-associated signaling pathways have been implicated in the process.In this study,we attempted to examine whe... Retinal ganglion cell(RGC) degeneration is irreversible in glaucoma and tyrosine kinase receptor B(Trk B)-associated signaling pathways have been implicated in the process.In this study,we attempted to examine whether imipramine,a tricyclic antidepressant,may protect hydrogen peroxide(H_2O_2)-induced RGC degeneration through the activation of the Trk B pathway in RGC-5 cell lines.RGC-5 cell lines were pre-treated with imipramine 30 minutes before exposure to H_2O_2.Western blot assay showed that in H_2O_2-damaged RGC-5 cells,imipramine activated Trk B pathways through extracellular signal-regulated protein kinase/Trk B phosphorylation.TUNEL staining assay also demonstrated that imipramine ameliorated H_2O_2-induced apoptosis in RGC-5 cells.Finally,Trk B-Ig G intervention was able to reverse the protective effect of imipramine on H_2O_2-induced RGC-5 apoptosis.Imipramine therefore protects RGCs from oxidative stress-induced apoptosis through the Trk B signaling pathway. 展开更多
关键词 nerve regeneration retinal ganglion cell imipramine oxidative stress apoptosis tyrosine kinase receptor B neural regeneration
下载PDF
Construction of a plasmid for human brain-derived neurotrophic factor and its effect on retinal pigment epithelial cell viability 被引量:2
2
作者 Bo-jing Yan Zhi-zhong Wu +1 位作者 Wei-hua Chong Gen-lin Li 《Neural Regeneration Research》 SCIE CAS CSCD 2016年第12期1981-1989,共9页
Several studies have investigated the protective functions of brain-derived neurotrophic factor(BDNF) in retinitis pigmentosa. However, a BDNF-based therapy for retinitis pigmentosa is not yet available. To develop ... Several studies have investigated the protective functions of brain-derived neurotrophic factor(BDNF) in retinitis pigmentosa. However, a BDNF-based therapy for retinitis pigmentosa is not yet available. To develop an efficient treatment for fundus disease, an eukaryotic expression plasmid was generated and used to transfect human 293 T cells to assess the expression and bioactivity of BDNF on acute retinal pigment epithelial-19(ARPE-19) cells, a human retinal epithelial cell line. After 96 hours of co-culture in a Transwell chamber, ARPE-19 cells exposed to BDNF secreted by 293 T cells were more viable than ARPE-19 cells not exposed to secreted BDNF. Western blot assay showed that Bax levels were downregulated and that Bcl-2 levels were upregulated in human ARPE-19 cells exposed to BDNF. Furthermore, 293 T cells transfected with the BDNF gene steadily secreted the protein. The powerful anti-apoptotic function of this BDNF may be useful for the treatment of retinitis pigmentosa and other retinal degenerative diseases. 展开更多
关键词 nerve regeneration neurodegenerative disease brain-derived neurotrophic factor retinitis pigmentosa retina retinal pigment epithelium biosynthesis transfection plasmids green fluorescent protein apoptosis cell survival neural regeneration
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部